Magnetite nanoparticle interactions with insulin amyloid fibrils

Area of Science:

• Biochemistry
• Materials Science
• Nanotechnology

Background:

• Amyloid fibril accumulation is implicated in Alzheimer's disease and other amyloidosis.
• Magnetic nanoparticles (NPs) offer diverse medical applications.

Purpose of the Study:

• To investigate the effects of iron(III) oxide (Fe3O4) NPs on insulin fibrillogenesis.
• To explore the binding affinity and interactions between Fe3O4 NPs and insulin fibrils.

Main Methods:

• Co-incubation of insulin with Fe3O4 NPs.
• Analysis of fibril structure and NP-fibril interactions.
• Zeta potential measurements to determine binding forces.

Main Results:

• Fe3O4 NPs did not alter the structural transformation of insulin into amyloid-like fibrils.
• Fe3O4 NPs exhibited higher affinity for pre-formed insulin fibrils.
• Binding was attributed to van der Waals forces, not surface charge, as both entities had positive zeta potentials.
• Varying amounts of Fe3O4 NPs did not affect the secondary structure of insulin fibrils.

Conclusions:

• Fe3O4 NPs interact with insulin amyloid fibrils via van der Waals forces.
• These findings suggest Fe3O4 NPs as potential therapeutic agents for protein aggregation diseases.
• Fe3O4 NPs may serve as contrast agents for magnetic resonance imaging in amyloidosis diagnosis.